The core activity of ObelysQ is to provide consulting services to the pharmaceutical industry, particularly in the area of clinical trials. This includes: GCP consulting (Good Clinical Practice), GCP and GVP audits (Good Clinical Practice and Good Vigilance Practice), development of Standard Operating Procedures (SOPs), preparation and support for inspections by health authorities, training and training for employees in the GCP/GVP area, conducting gap analyses to identify areas for improvement, support for the implementation of EU-CTR (European Clinical Trials Regulation), data protection support, and review of audit reports and CAPAs (Corrective and Preventive Actions). The company thus offers comprehensive consulting services to improve compliance and quality of clinical trials in the pharmaceutical industry.